Ignite Creation Date:
2024-05-06 @ 10:14 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03205176
Status:
COMPLETED
Last Update Posted:
2021-05-06
First Post:
2017-06-23
Brief Title:
AZD5153 in Patients With Relapsed or Refractory Solid Tumors Including Lymphomas
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-23
First Submit QC Date:
June 29 2017
Study First Post Date:
2017-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-05
Last Update Post Date:
2021-05-06
Last Update Post Date Type:
ACTUAL